Avoid Primidone and Switch to Levetiracetam or Lamotrigine for Focal Seizures
Do not use primidone with apixaban—primidone is a strong CYP3A4 and P-gp inducer that will significantly reduce apixaban levels and increase stroke/PE recurrence risk. The FDA label explicitly states to avoid concomitant use of apixaban with combined P-gp and strong CYP3A4 inducers 1. Primidone, which metabolizes to phenobarbital, is a potent enzyme inducer that will decrease apixaban exposure to potentially subtherapeutic levels 2.
Recommended Alternative Antiepileptic Drugs
For focal seizures in this patient, switch to levetiracetam or lamotrigine as first-line alternatives—both are effective for focal epilepsy and have no clinically significant interactions with apixaban 3.
Primary Options (No Drug Interactions):
Levetiracetam: Excellent choice with no CYP450 or P-gp interactions, favorable cognitive profile, and proven efficacy for focal seizures 3, 4. This is the safest option from a drug interaction standpoint.
Lamotrigine: Equally effective as carbamazepine for focal epilepsy with superior tolerability and no enzyme-inducing effects 5, 3. No interaction with apixaban.
Additional Safe Alternatives:
- Gabapentin: No enzyme induction, favorable cognitive profile, no interaction with DOACs 4
- Topiramate: No clinically significant CYP3A4 induction, though monitor for other side effects 3, 4
- Zonisamide: Minimal drug interactions, effective for focal seizures 3, 4
- Lacosamide: Proven efficacy for focal epilepsy, no significant pharmacokinetic interactions 3
Critical Drugs to Avoid with Apixaban
The following antiepileptic drugs are contraindicated due to strong enzyme induction that reduces apixaban levels 1, 2:
- Primidone (the drug in question)
- Phenytoin
- Carbamazepine
- Phenobarbital
These agents induce both CYP3A4 and P-gp, causing a 50-60% reduction in apixaban exposure, which dramatically increases thrombotic risk 6.
Management Strategy
- Do not start primidone—explain to the provider that this creates an unacceptable thrombotic risk
- Initiate levetiracetam or lamotrigine for focal seizure control
- Continue apixaban at current dose without modification
- If primidone was already started: A case report describes a washout period based on primidone's 10-15 hour half-life (approximately 5-7 days) before apixaban levels normalize 7
Clinical Pitfalls
- Do not attempt dose adjustment of apixaban to compensate for enzyme induction—there is no validated dosing strategy, and plasma level monitoring is not routinely available 7
- Switching to warfarin is not a solution—primidone also induces CYP2C9, affecting warfarin metabolism and making INR control extremely difficult 6
- Oxcarbazepine is NOT a safe alternative—while less enzyme-inducing than carbamazepine, it still has some CYP3A4 induction and causes hyponatremia more frequently 4
The evidence strongly supports using non-enzyme-inducing antiepileptic drugs in patients requiring DOACs 6, 1. Levetiracetam offers the cleanest pharmacokinetic profile with proven efficacy for focal seizures 3.